India's Ajanta Pharma promoter sells stake worth about 10.24 billion rupees
India's Ajanta Pharma promoter sells stake worth about 10.24 billion rupees June 9 (Reuters) - A promoter entity of India's Ajanta Pharma AJPH.NS sold shares worth 10.24 billion rupees ($107.4 million) via bulk deal on Tuesday, according to exchange data.
Here are the details:
Ravi Agrawal Trust, a promoter group entity of the drugmaker, sold 3.5 million shares, representing about 2.8% stake, according to bulk deal data from the National Stock Exchange of India
Shares were sold at 2,968 rupees each, which is at a 0.03% discount to Monday's closing price
Kotak Mahindra Mutual Fund and Aditya Birla Sun Life Mutual Fund bought 2.1 million and 1.3 million shares of Ajanta Pharma, respectively
Ravi Agrawal Trust held 16.2 million shares in the firm, equivalent to a 13% stake, according to exchange data as of March-end
In December 2022, promoters Ravi Agrawal Trust and Aayush Agrawal Trust had together sold about 4.6% stake in Ajanta Pharma via a block deal, according to an Economic Times report.
($1 = 95.3500 Indian rupees)
(Reporting by Anuran Sadhu in Bengaluru; Editing by Shailesh Kuber)
((Anuran.Sadhu@thomsonreuters.com; +91 8697274436;))
Recent news on Ajanta Pharma
See all newsIndia's Ajanta Pharma falls as analysts say growth to moderate in H2
Brief: Ajanta Pharma Limited Sept-Quarter Consol Net Profit 3.88 Billion Rupees
India's Ajanta Pharma jumps on June quarter profit jump
Brief: Ajanta Pharma June-Quarter Consol PAT 3.34 Billion Rupees
Brief: Ajanta Pharma Receives US FDA Establishment Inspection Report For Paithan Facility